These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 31827072)

  • 21. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii.
    Denkers EY
    FEMS Immunol Med Microbiol; 2003 Dec; 39(3):193-203. PubMed ID: 14642303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Co-administration of interleukins 7 and 15 with DNA vaccine improves protective immunity against Toxoplasma gondii.
    Chen J; Li ZY; Petersen E; Liu WG; Zhu XQ
    Exp Parasitol; 2016 Mar; 162():18-23. PubMed ID: 26706605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Innate responses to Toxoplasma gondii in mice and humans.
    Pifer R; Yarovinsky F
    Trends Parasitol; 2011 Sep; 27(9):388-93. PubMed ID: 21550851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GABARAPL2 Is Critical for Growth Restriction of Toxoplasma gondii in HeLa Cells Treated with Gamma Interferon.
    Zhang Z; Gu H; Li Q; Zheng J; Cao S; Weng C; Jia H
    Infect Immun; 2020 Apr; 88(5):. PubMed ID: 32094251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C5aR1 Activation Drives Early IFN-γ Production to Control Experimental
    Briukhovetska D; Ohm B; Mey FT; Aliberti J; Kleingarn M; Huber-Lang M; Karsten CM; Köhl J
    Front Immunol; 2020; 11():1397. PubMed ID: 32733463
    [No Abstract]   [Full Text] [Related]  

  • 26. Immune response and immunopathology during toxoplasmosis.
    Dupont CD; Christian DA; Hunter CA
    Semin Immunopathol; 2012 Nov; 34(6):793-813. PubMed ID: 22955326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ATF6β-dependent host adaptive immune response by a Toxoplasma virulence factor ROP18.
    Yamamoto M; Takeda K
    Virulence; 2012; 3(1):77-80. PubMed ID: 22286708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response against toxoplasmosis-some recent updates RH:
    Sana M; Rashid M; Rashid I; Akbar H; Gomez-Marin JE; Dimier-Poisson I
    Int J Immunopathol Pharmacol; 2022; 36():3946320221078436. PubMed ID: 35227108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a DNA vaccine encoding Toxoplasma gondii Superoxide dismutase (TgSOD) induces partial immune protection against acute toxoplasmosis in BALB/c mice.
    Liu Y; Cao A; Li Y; Li X; Cong H; He S; Zhou H
    BMC Infect Dis; 2017 Jun; 17(1):403. PubMed ID: 28592247
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Murine Irgm Paralogs Regulate Nonredundant Functions To Execute Host Defense to Toxoplasma gondii.
    Dockterman J; Fee BE; Taylor GA; Coers J
    Infect Immun; 2021 Oct; 89(11):e0020221. PubMed ID: 34338548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β in Toxoplasmosis: Friend or foe?
    Zare-Bidaki M; Assar S; Hakimi H; Abdollahi SH; Nosratabadi R; Kennedy D; Arababadi MK
    Cytokine; 2016 Oct; 86():29-35. PubMed ID: 27449809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Toxoplasma gondii Rhoptry Kinome Is Essential for Chronic Infection.
    Fox BA; Rommereim LM; Guevara RB; Falla A; Hortua Triana MA; Sun Y; Bzik DJ
    mBio; 2016 May; 7(3):. PubMed ID: 27165797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune response and protective effect against chronic Toxoplasma gondii infection induced by vaccination with a DNA vaccine encoding profilin.
    Gao Q; Zhang NZ; Zhang FK; Wang M; Hu LY; Zhu XQ
    BMC Infect Dis; 2018 Mar; 18(1):117. PubMed ID: 29514647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Rudolf-Virchow Prize 1998. Award lecture. Toxoplasmosis: a model infection for studying systemic and intracerebral immune reactions].
    Deckert-Schlüter M
    Verh Dtsch Ges Pathol; 1998; 82():9-22. PubMed ID: 10095413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell-mediated immunity to Toxoplasma gondii develops primarily by local Th1 host immune responses in the absence of parasite replication.
    Gigley JP; Fox BA; Bzik DJ
    J Immunol; 2009 Jan; 182(2):1069-78. PubMed ID: 19124750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guanylate-binding protein 1 (Gbp1) contributes to cell-autonomous immunity against Toxoplasma gondii.
    Selleck EM; Fentress SJ; Beatty WL; Degrandi D; Pfeffer K; Virgin HW; Macmicking JD; Sibley LD
    PLoS Pathog; 2013; 9(4):e1003320. PubMed ID: 23633952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complex immune cell interplay in the gamma interferon response during Toxoplasma gondii infection.
    Sturge CR; Yarovinsky F
    Infect Immun; 2014 Aug; 82(8):3090-7. PubMed ID: 24866795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coinfection with Heligmosomoides polygyrus fails to establish CD8+ T-cell immunity against Toxoplasma gondii.
    Khan IA; Hakak R; Eberle K; Sayles P; Weiss LM; Urban JF
    Infect Immun; 2008 Mar; 76(3):1305-13. PubMed ID: 18195022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Host resistance and immune deviation in pigeon cytochrome c T-cell receptor transgenic mice infected with Toxoplasma gondii.
    Collazo CM; Miller C; Yap G; Hieny S; Caspar P; Schwartz RH; Sher A
    Infect Immun; 2000 May; 68(5):2713-9. PubMed ID: 10768964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.